How we achieve high level corporate partnerships with companies given the health advocacy and promotion priorities of the UICC and some of the

Similar documents
TOGETHER WE ARE STRONGER

2015 has been a landmark year in the fight to end the global tobacco epidemic.

IOGT International. Klara Södra Kyrkogata 20 SE Stockholm Sweden M:

NCD Alliance Strategic Plan

WHO Reform: Engagement with non-state actors

The role of civil society as advocates and watchdogs in. NCD prevention and control in the Caribbean

CAMPAIGN FUEL. An NCD Alliance guide to social media campaigning for the 2018 UN High-Level Meeting on NCDs

TERMS OF REFERENCE FOR THE UN INTERAGENCY TASK FORCE ON THE PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES

7 March Excellency,

Advocating: Lobbying vs. Educating. Providing Information and Education to Policy Makers Alaska Health Summit, January

ANNUAL REPORT

The future of financing for WHO 2010 ARGENTINA

Corporate Accountability International s Response to the WHO s Public Web Consultation on Engagement with Non-State Actors 20 March 2013

NCD Alliance Webinar Wednesday 22 July 2015

Taking on the Lethal but Legal Industries: Strategies to Change Corporate Practices that Harm Health

Collaboration with the private sector. Thursday 20 March 2013

Thought Leader Summary. Heather Conley SVP for Europe, Eurasia, and the Arctic; and Director, Europe Program, CSIS

Framework of engagement with non-state actors

Five Roles of Political Parties

How to use the public health duty to Do No Harm

The recent UN MDG Gap report is very instructive and it is essential reading for anyone seriously concerned about development co-operation.

Key findings from the SMShealth.eu network

African Regional Workshop on Implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC) Dakar, Senegal, 9-12 October 2012

Responses to the Public web consultation on WHO s engagement with non-state actors

WHA69.R10 Framework of Engagement with Non-State Actors (FENSA)

Lobby and advocacy training Safeguarding Refugee Protection in Bulgaria

Athens Declaration for Healthy Cities

EUROCARE COMMENTS TO THE DISCUSSION PAPER FOR THE INFORMAL CONSULTATION WITH MEMBER STATES AND NON-STATE ACTORS

WHO Headquarters, Geneva, Salle D, April Lessons learned from CARICOM on NCD prevention and control. Dr George Alleyne

Position Description

Exploring Civilian Protection: A Seminar Series

Health in All Policies and Health impact assessment

Framework of engagement with non-state actors

AMERICAN BAR ASSOCIATION. ADOPTED BY THE HOUSE OF DELEGATES February 13, 2006 RECOMMENDATION

Table Of Content. EPHA 2015: Protecting and improving public health and well-being in all policies... 2 Summary... 3 Work Package...

Developing a Costed National Multisectoral Action Plan for Prevention and Control of NCDs

Initiatives within the UN system to increase environmental security in relation to armed conflicts

Informal information session (briefing) for Member States Geneva, 4 March 2015

2020 and/or 2022 World Cancer Congress Bid Manual

PCIJ: What are the specific details that the administration wants to hammer out?

Sustainable measures to strengthen implementation of the WHO FCTC

This cartoon depicts the way that -- all too often -- evidence is used in the policymaking process. Our goal is to do better.

Thailand s National Health Assembly a means to Health in All Policies

Seminar on global health diplomacy

ANNEX DRAFT OVERARCHING FRAMEWORK OF ENGAGEMENT WITH NON-STATE ACTORS

URGENT NEED FOR AN ALTERNATIVE INTERNATIONAL AGENDA FOR CHANGE (Beyond 2015)

Nordic Specialist Meeting Health in All Policies

Implementation of the Framework of engagement with non-state actors (FENSA)

Generating political priority for global health initiatives

The Demand: Where Sex Trafficking Begins

Framework of engagement with non-state actors

Ladies and gentlemen,

WHO DISCUSSION PAPER

The Emergence of a EU Lifestyle Policy

GLOBAL VILLAGE MODEL UNITED NATIONS

Stiglitz: Europe's View on Inequality

Public/Private Partnerships: A Framework for Moving Ahead. June 16, 2015 Sylvia Rowe SR Strategy

H.E. Mr. Khaled Shamaa Chair of the 57th session of the Commission on Narcotic Drugs (CND) Permanent Representative of the Arab Republic of Egypt to

Framework of engagement with non-state actors

Becoming A City of Peace

Pan Europa Bulgaria 7 January 2016 speech on Dutch EU presidency 2016

TERMS OF REFERENCE YHCWG1044

WHO reform: Framework of engagement with non-state actors

Lost in Austerity: rethinking the community sector

n The consensus of late 19 th century political thought was that a monarchy was needed to restrain the destructive tendency of faction.

Sectoral cooperation in the prevention and control of Noncommunicable diseases

Who Is End Citizens United?

Gender Thematic Group (GTG) Meeting

A CANADIAN NORTH STAR:

NCD Alliance Webinar Wednesday 26 February 2014

Ensuring no one is left behind: The Linkages between the Cooperative Model and the United Nations 2030 Agenda for the Sustainable Development

YOUNG DIPLOMATS TOUR 2016

Overview Paper. Decent work for a fair globalization. Broadening and strengthening dialogue

Advocacy Cycle Stage 4

Governance Challenges in Global Health

A growing competence: The unfinished story of the European Union health policy

Ekspertmøte om helsepersonellkrisen, Soria Moria, 24 February 2005.

Conflicts of Interest concerns about three members of WHO s new High-level Commission on NCDs 2

icd - institute for cultural diplomacy

ZIMBABWE ELECTION SUPPORT NETWORK

HIGHLIGHTS OF THE 9 TH SESSION OF THE JOINT NGO BRIEFING SERIES 21 February 2013

Towards Operationalizing Multi- Sectoral Approaches in NCD Prevention in Africa

OVERCOMING UNION RESISTANCE TO EQUITY ISSUES AND STRUCTURES 1

The Egyptian Cabinet Information and Decision Support Center

Recent developments in technology and better organisation have allowed

DIRECCIÓN GENERAL DE PLANIFICACIÓN Y EVALUACIÓN DE POLÍTICAS PARA EL DESARROLLO DEVELOPMENT EDUCATION STRATEGY PAPER SPANISH DEVELOPMENT COOPERATION

Guidelines for the new APHA for affiliated associations APRIL 2014

THE NPT, NUCLEAR DISARMAMENT, AND TERRORISM

All for One and One for All: Promising Practices for Consumer Health Advocacy Collaboration

Joint Press briefing by Foreign Secretary Shri Shivshankar Menon And U.S. Under Secretary of State for Political Affairs Mr.

CD50/INF/6 (Eng.) Annex F

Safeguarding against possible conflicts of interest in nutrition programmes

NCD Alliance Report. Putting non-communicable diseases on the global agenda. The NCD Alliance was founded by:

Understanding. Federalist 10. Learning Objectives

Final Technical Report on the Proposal PGTF- INT/10/k01, Award number project number

Office for the Coordination of Humanitarian Affairs. Assistant-Secretary-General and Deputy Emergency Relief Coordinator Kyung-wha Kang

Discussion on International Communication and IS in run up to WSIS

POST-2015: BUSINESS AS USUAL IS NOT AN OPTION Peacebuilding, statebuilding and sustainable development

The United States & Latin America: After The Washington Consensus Dan Restrepo, Director, The Americas Program, Center for American Progress

Boundaries to business action at the public policy interface Issues and implications for BP-Azerbaijan

Transcription:

How we achieve high level corporate partnerships with companies given the health advocacy and promotion priorities of the UICC and some of the challenges that arise in a global context.

World Cancer Declaration

3 Key Questions Can we deliver the World Cancer Declaration targets without engaging the private sector? Which corporate players should we work with and partner? Conflict of interest in Global Advocacy?

Essential to our future

Not essential to our future

Corporate impact Nearly 70% of the working population is employed by the private sector

Key Questions Can we deliver the World Cancer Declaration targets without engaging the private sector? Which corporate players should we work with and partner? Conflict of interest in Global Advocacy?

An extreme view An NGO should not associate itself in any way with a private sector company because there is an inherent conflict of interest. Taking restricted or unrestricted funding is irrelevant An NGO which takes private sector funding is a BINGO (Business Interest NGO) and their view will be affected by the relationship An NGO which does not is a PINGO (Public Interest NGO)

Ranges of possibilities Within the UICC membership we have a wide range of NGOs which do or do not have relationships with the private sector Some have relationships with sub-brands of large corporate entities, but not the main corporate. Some have local or regional relationships but not global relationships. Restricted and unrestricted

UICC enjoys positive partnerships with many organisations UN AGENCIES Ecosoc status with the United Nations Formal Relations with WHO Partner with IAEA and IARC

UICC enjoys positive partnerships with many organisations

It s not simply black and white Avoid Talk Partner

High Cause Weak Nil Negative Hinders Local Negative Partner Assessment Framework Conflict Direct Impact on Cancer and NCDs Complementary Skills/Expertise/Assets CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Low Solve Strong Active Effective Helps Global Positive Avoid Talk Partner

High Cause Weak Nil Negative Hinders Local Negative Example 1: tobacco company Conflict Direct Impact on Cancer and NCDs Complementary Skills/Expertise/Assets CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Low Solve Strong Active Effective Helps Global Positive Avoid Talk Partner

High Cause Weak Nil Negative Hinders Local Negative Example 3: food and beverage Conflict Direct Impact on Cancer and NCDs Complementary Skills/Expertise/Assets CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Low Solve Strong Active Effective Helps Global Positive Avoid Talk Partner

3 Key Questions Can we solve the global cancer and NCD challenge without engaging the private sector? Which corporate players should we work with and partner? Conflict of interest in Global Advocacy?

Global advocacy involves everyone. Everyone is involved in global advocacy for health UN, WHO, governments, private sector, academia, civil society, individuals, you. Alliances both formal and informal form on a regular basis linked to a theme, an issue or in opposition to another view Players can adopt several positions on the same issue (or change position quickly for no apparent reason) Strange alliances emerge and unexpected positions can be adopted sometimes linked to completely unrelated issues There are few pure right/correct views, and compromise (consensus) dominates thinking as a good result Trading takes place The words used are incredibly important Many players are skilled diplomats and politicians not enthusiastic amateurs There are many tourists and side shows

It s not simply black and white advocay response Avoid/ counter Talk/ coerce Partner/ plan

Key things for success Know what you want Proposed Outcomes Document from the NCD Alliance Support your demands with evidence Have a plan and the resource to execute the plan Understand who can influence the outcome you want (in the UN system, member states, individuals, other organisations) Get to them professionally and effectively Choose your partners/allies wisely, issue by issue Counter the opposition Stay the course

Impact on partnerships You don t have to agree on everything Transparency in the relationship is critical A firewall on policy issues is critical Use independent scientific evidence to substantiate all positions you adopt What s the economic argument for action? Head, heart and pocket

Measuring success A UN High Level Meeting on NCDs An increased understanding and awareness of NCDs around the world no longer the forgotten diseases A global goal to reduce premature deaths throgh NCDs by 25% by 2025 A commitment to agree 10 targets and many indicators to measure progress, by the end of 2012 NCDs in the replacement MDGs in 2015